Cargando…
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930929/ https://www.ncbi.nlm.nih.gov/pubmed/35254628 http://dx.doi.org/10.1007/s40261-022-01123-z |
| _version_ | 1784671143746076672 |
|---|---|
| author | Tepper, Stewart J. Ailani, Jessica Ford, Janet H. Nichols, Russell M. Li, Lily Q. Kemmer, Phebe Hand, Austin L. Tockhorn-Heidenreich, Antje |
| author_facet | Tepper, Stewart J. Ailani, Jessica Ford, Janet H. Nichols, Russell M. Li, Lily Q. Kemmer, Phebe Hand, Austin L. Tockhorn-Heidenreich, Antje |
| author_sort | Tepper, Stewart J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8930929 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89309292022-04-01 Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) Tepper, Stewart J. Ailani, Jessica Ford, Janet H. Nichols, Russell M. Li, Lily Q. Kemmer, Phebe Hand, Austin L. Tockhorn-Heidenreich, Antje Clin Drug Investig Correction Springer International Publishing 2022-03-07 2022 /pmc/articles/PMC8930929/ /pubmed/35254628 http://dx.doi.org/10.1007/s40261-022-01123-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Tepper, Stewart J. Ailani, Jessica Ford, Janet H. Nichols, Russell M. Li, Lily Q. Kemmer, Phebe Hand, Austin L. Tockhorn-Heidenreich, Antje Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) |
| title | Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) |
| title_full | Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) |
| title_fullStr | Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) |
| title_full_unstemmed | Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) |
| title_short | Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) |
| title_sort | correction to: effects of galcanezumab on health-related quality of life and disability in patients with previous failure of 2–4 migraine preventive medication categories: results from a phase iiib randomized, placebo-controlled, multicenter clinical trial (conquer) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930929/ https://www.ncbi.nlm.nih.gov/pubmed/35254628 http://dx.doi.org/10.1007/s40261-022-01123-z |
| work_keys_str_mv | AT tepperstewartj correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT ailanijessica correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT fordjaneth correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT nicholsrussellm correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT lililyq correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT kemmerphebe correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT handaustinl correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer AT tockhornheidenreichantje correctiontoeffectsofgalcanezumabonhealthrelatedqualityoflifeanddisabilityinpatientswithpreviousfailureof24migrainepreventivemedicationcategoriesresultsfromaphaseiiibrandomizedplacebocontrolledmulticenterclinicaltrialconquer |